Keyword Search: Gene Ontology, PubMed or Web (Google)

PDB Keywords for 1I5J

(Keywords from the PDB file are used here. They may or may not correspond to GO term names).

• Protein-Lipid Interaction|Amphipathic Alpha Helix|Lipid Transport [GO] [PubMed] [Google]

GO Keywords for 1I5J

(Here all GO term names are given that map directly to this particular structure).

• retinoid metabolic process [GO] [PubMed] [Google]
• extracellular region [GO] [PubMed] [Google]
• extracellular space [GO] [PubMed] [Google]
• early endosome [GO] [PubMed] [Google]
• lipid metabolic process [GO] [PubMed] [Google]
• transport [GO] [PubMed] [Google]
• lipid transport [GO] [PubMed] [Google]
• enzyme activator activity [GO] [PubMed] [Google]
• lipid binding [GO] [PubMed] [Google]
• positive regulation of phospholipase activity [GO] [PubMed] [Google]
• positive regulation of triglyceride catabolic process [GO] [PubMed] [Google]
• positive regulation of very-low-density lipoprotein particle remodeling [GO] [PubMed] [Google]
• negative regulation of very-low-density lipoprotein particle clearance [GO] [PubMed] [Google]
• phospholipase activator activity [GO] [PubMed] [Google]
• lipid catabolic process [GO] [PubMed] [Google]
• negative regulation of cholesterol transport [GO] [PubMed] [Google]
• cholesterol efflux [GO] [PubMed] [Google]
• phospholipid efflux [GO] [PubMed] [Google]
• very-low-density lipoprotein particle [GO] [PubMed] [Google]
• low-density lipoprotein particle [GO] [PubMed] [Google]
• intermediate-density lipoprotein particle [GO] [PubMed] [Google]
• high-density lipoprotein particle [GO] [PubMed] [Google]
• spherical high-density lipoprotein particle [GO] [PubMed] [Google]
• triglyceride-rich lipoprotein particle remodeling [GO] [PubMed] [Google]
• chylomicron remodeling [GO] [PubMed] [Google]
• very-low-density lipoprotein particle remodeling [GO] [PubMed] [Google]
• chylomicron remnant clearance [GO] [PubMed] [Google]
• high-density lipoprotein particle clearance [GO] [PubMed] [Google]
• lipoprotein metabolic process [GO] [PubMed] [Google]
• chylomicron [GO] [PubMed] [Google]
• cholesterol homeostasis [GO] [PubMed] [Google]
• protein homodimerization activity [GO] [PubMed] [Google]
• negative regulation of catalytic activity [GO] [PubMed] [Google]
• phospholipase binding [GO] [PubMed] [Google]
• reverse cholesterol transport [GO] [PubMed] [Google]
• positive regulation of fatty acid biosynthetic process [GO] [PubMed] [Google]
• negative regulation of lipid metabolic process [GO] [PubMed] [Google]
• negative regulation of receptor-mediated endocytosis [GO] [PubMed] [Google]
• positive regulation of lipoprotein lipase activity [GO] [PubMed] [Google]
• lipase inhibitor activity [GO] [PubMed] [Google]
• lipoprotein lipase activator activity [GO] [PubMed] [Google]
• positive regulation of phospholipid catabolic process [GO] [PubMed] [Google]
• extracellular exosome [GO] [PubMed] [Google]
• triglyceride homeostasis [GO] [PubMed] [Google]